Company Performance Metrics
Joe Cooper: CEOPast Role: Medicis Pharmaceutical, Executive Vice President
Derek Overstreet: Co-Founder, Chief Executive Officer, & DirectorPast Role: Sonoran Biosciences, co-founder and Chief Scientific Officer
Sonoran Biosciences is a privately held early stage pharmaceutical company that has developed SB Gel, the first viscous sustained release carrier. SB Gel enables sustained release of a wide variety of pharmaceuticals to new sites in the body, including joints, device surfaces, and healing tissues. We develop new formulations using approved active
ingredients, requiring reduced development cost and risk via the 505(b)(2) approval pathway while retaining the exclusivity of a typical pharmaceutical. Formulations based on SB Gel have potential in a number of indications including deep infection, pain management, and wound healing. Our first product, SB Gel with tobramycin, is being developed for treatment of prosthetic joint infection in a one-stage surgical approach.
